_id
69171ad93c536f8df23165cf
Ticker
SYBE
Name
SYBLEU INC.
Exchange
PINK
Address
1034 Throggs Neck Expressway, Bronx, NY, United States, 10465
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a subsidiary of Worldwide Holdings, LLC.
Last Close
0.055
Volume
-
Current Price
0.055
Change
0
Last Updated
2026-01-07T12:44:09.899Z
Image
-
Ipo Date
-
Market Cap
583742
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-12-31
Revenue
2949
Cost Of Revenue
-
Gross Profit
2949
Operating Expenses
18111
Operating Income
-15162
Interest Expense
12260
Pretax Income
-20221
Net Income
-20221
Eps
-0.0019052164923665086
Dividends Per Share
-
Shares Outstanding
10613492
Income Tax Expense
12681
EBITDA
-15161
Operating Margin
-514.1403865717192
Total Other Income Expense Net
-5059
Cash
175
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
11214
Property Plant Equipment
-
Total Assets
304154
Payables
-
Short Term Debt
188500
Long Term Debt
300000
Total Liabilities
694114
Equity
-389960
Bs_currency_symbol
USD
Depreciation
5320
Change In Working Capital
28227
Cash From Operations
-5457
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
5500
Net Change In Cash
43
Cf_currency_symbol
USD
PE
-
PB
-1.4969280439019388
ROE
5.185403631141656
ROA
-6.648276859748679
FCF
-5457
Fcf Percent
-1.8504577822990844
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2023-12-31
Quarters > 0 > income Statement > revenue
2949
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
2949
Quarters > 0 > income Statement > operating Expenses
18111
Quarters > 0 > income Statement > operating Income
-15162
Quarters > 0 > income Statement > interest Expense
12260
Quarters > 0 > income Statement > pretax Income
-20221
Quarters > 0 > income Statement > net Income
-20221
Quarters > 0 > income Statement > eps
-0.0019052164923665086
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10613492
Quarters > 0 > income Statement > income Tax Expense
12681
Quarters > 0 > income Statement > EBITDA
-15161
Quarters > 0 > income Statement > operating Margin
-514.1403865717192
Quarters > 0 > income Statement > total Other Income Expense Net
-5059
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
175
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11214
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
304154
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
188500
Quarters > 0 > balance Sheet > long Term Debt
300000
Quarters > 0 > balance Sheet > total Liabilities
694114
Quarters > 0 > balance Sheet > equity
-389960
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20221
Quarters > 0 > cash Flow > depreciation
5320
Quarters > 0 > cash Flow > change In Working Capital
28227
Quarters > 0 > cash Flow > cash From Operations
-5457
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
5500
Quarters > 0 > cash Flow > net Change In Cash
43
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0019052164923665086
Quarters > 0 > ratios > PB
-1.4969280439019388
Quarters > 0 > ratios > ROE
5.185403631141656
Quarters > 0 > ratios > ROA
-6.648276859748679
Quarters > 0 > ratios > FCF
-5457
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.8504577822990844
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2023-09-30
Quarters > 1 > income Statement > revenue
2949
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
2949
Quarters > 1 > income Statement > operating Expenses
134993
Quarters > 1 > income Statement > operating Income
-126724
Quarters > 1 > income Statement > interest Expense
12097
Quarters > 1 > income Statement > pretax Income
-145639
Quarters > 1 > income Statement > net Income
-145639
Quarters > 1 > income Statement > eps
-0.013722062446553877
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
10613492
Quarters > 1 > income Statement > income Tax Expense
13595
Quarters > 1 > income Statement > EBITDA
-125850
Quarters > 1 > income Statement > operating Margin
-4297.185486605629
Quarters > 1 > income Statement > total Other Income Expense Net
-14468
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
132
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
9451
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
313703
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
183000
Quarters > 1 > balance Sheet > long Term Debt
300000
Quarters > 1 > balance Sheet > total Liabilities
687475
Quarters > 1 > balance Sheet > equity
-373772
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-145639
Quarters > 1 > cash Flow > depreciation
5320
Quarters > 1 > cash Flow > change In Working Capital
136486
Quarters > 1 > cash Flow > cash From Operations
-9154
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
5500
Quarters > 1 > cash Flow > net Change In Cash
-3654
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.013722062446553877
Quarters > 1 > ratios > PB
-1.5617597358817674
Quarters > 1 > ratios > ROE
38.964662949605646
Quarters > 1 > ratios > ROA
-46.425759396626745
Quarters > 1 > ratios > FCF
-9154
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.104103085791794
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2023-06-30
Quarters > 2 > income Statement > revenue
2916
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2916
Quarters > 2 > income Statement > operating Expenses
112758
Quarters > 2 > income Statement > operating Income
-109842
Quarters > 2 > income Statement > interest Expense
3869
Quarters > 2 > income Statement > pretax Income
-112993
Quarters > 2 > income Statement > net Income
-112993
Quarters > 2 > income Statement > eps
-0.011153635747860097
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10130598
Quarters > 2 > income Statement > income Tax Expense
3869
Quarters > 2 > income Statement > EBITDA
-109842
Quarters > 2 > income Statement > operating Margin
-3766.8724279835387
Quarters > 2 > income Statement > total Other Income Expense Net
-3151
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3786
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
19399
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
330468
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
177500
Quarters > 2 > balance Sheet > long Term Debt
300000
Quarters > 2 > balance Sheet > total Liabilities
681413
Quarters > 2 > balance Sheet > equity
-350945
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-112993
Quarters > 2 > cash Flow > depreciation
-718
Quarters > 2 > cash Flow > change In Working Capital
15969
Quarters > 2 > cash Flow > cash From Operations
-36102
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
37500
Quarters > 2 > cash Flow > net Change In Cash
1398
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.011153635747860097
Quarters > 2 > ratios > PB
-1.5876644203507673
Quarters > 2 > ratios > ROE
32.196782971690716
Quarters > 2 > ratios > ROA
-34.19181282302674
Quarters > 2 > ratios > FCF
-36102
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-12.380658436213992
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-03-31
Quarters > 3 > income Statement > revenue
2883
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
2883
Quarters > 3 > income Statement > operating Expenses
24793
Quarters > 3 > income Statement > operating Income
-24625
Quarters > 3 > income Statement > interest Expense
3411
Quarters > 3 > income Statement > pretax Income
-29034
Quarters > 3 > income Statement > net Income
-29034
Quarters > 3 > income Statement > eps
-0.0028176061469114633
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10304492
Quarters > 3 > income Statement > income Tax Expense
3411
Quarters > 3 > income Statement > EBITDA
-20912
Quarters > 3 > income Statement > operating Margin
-854.1449878598681
Quarters > 3 > income Statement > total Other Income Expense Net
-4409
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2388
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
23760
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
34112
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
140000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
329229
Quarters > 3 > balance Sheet > equity
-295117
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-29034
Quarters > 3 > cash Flow > depreciation
3713
Quarters > 3 > cash Flow > change In Working Capital
-10050
Quarters > 3 > cash Flow > cash From Operations
-34460
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
37500
Quarters > 3 > cash Flow > net Change In Cash
-34460
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.0028176061469114633
Quarters > 3 > ratios > PB
-1.9204148185296002
Quarters > 3 > ratios > ROE
9.838131995107027
Quarters > 3 > ratios > ROA
-85.11374296435272
Quarters > 3 > ratios > FCF
-34460
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-11.95282691640652
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
11696
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
11696
Annuals > 0 > income Statement > operating Expenses
160876
Annuals > 0 > income Statement > operating Income
-149180
Annuals > 0 > income Statement > interest Expense
14221
Annuals > 0 > income Statement > pretax Income
-180304
Annuals > 0 > income Statement > net Income
-180304
Annuals > 0 > income Statement > eps
-0.01745617054193769
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10328955
Annuals > 0 > income Statement > income Tax Expense
14221
Annuals > 0 > income Statement > EBITDA
-141571
Annuals > 0 > income Statement > operating Margin
-1275.4787961696306
Annuals > 0 > income Statement > total Other Income Expense Net
-31124
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
36848
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
53084
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
60999
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
140000
Annuals > 0 > balance Sheet > long Term Debt
300000
Annuals > 0 > balance Sheet > total Liabilities
327082
Annuals > 0 > balance Sheet > equity
-266083
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-180304
Annuals > 0 > cash Flow > depreciation
7609
Annuals > 0 > cash Flow > change In Working Capital
18281
Annuals > 0 > cash Flow > cash From Operations
-100564
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
37500
Annuals > 0 > cash Flow > net Change In Cash
-63064
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.01745617054193769
Annuals > 0 > ratios > PB
-2.135019993761345
Annuals > 0 > ratios > ROE
67.76231476644506
Annuals > 0 > ratios > ROA
-295.5851735274349
Annuals > 0 > ratios > FCF
-100564
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-8.598153214774282
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
11700
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
11700
Annuals > 1 > income Statement > operating Expenses
68073
Annuals > 1 > income Statement > operating Income
-56373
Annuals > 1 > income Statement > interest Expense
13252
Annuals > 1 > income Statement > pretax Income
-245347
Annuals > 1 > income Statement > net Income
-245347
Annuals > 1 > income Statement > eps
-0.023116519991723743
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10613492
Annuals > 1 > income Statement > income Tax Expense
13253
Annuals > 1 > income Statement > EBITDA
119348
Annuals > 1 > income Statement > operating Margin
-481.8205128205128
Annuals > 1 > income Statement > total Other Income Expense Net
-188974
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
66850
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
66850
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
76379
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
140000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
326339
Annuals > 1 > balance Sheet > equity
-249960
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-245347
Annuals > 1 > cash Flow > depreciation
175721
Annuals > 1 > cash Flow > change In Working Capital
166819
Annuals > 1 > cash Flow > cash From Operations
-78528
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
131081
Annuals > 1 > cash Flow > net Change In Cash
52553
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.023116519991723743
Annuals > 1 > ratios > PB
-2.3353418947031526
Annuals > 1 > ratios > ROE
98.15450472075533
Annuals > 1 > ratios > ROA
-321.22311106455965
Annuals > 1 > ratios > FCF
-78528
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-6.711794871794872
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
4052
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
4052
Annuals > 2 > income Statement > operating Expenses
92304
Annuals > 2 > income Statement > operating Income
-88252
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-80452
Annuals > 2 > income Statement > net Income
-101846
Annuals > 2 > income Statement > eps
-0.009595899257284973
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
10613492
Annuals > 2 > income Statement > income Tax Expense
21394
Annuals > 2 > income Statement > EBITDA
-88252
Annuals > 2 > income Statement > operating Margin
-2177.986179664363
Annuals > 2 > income Statement > total Other Income Expense Net
7800
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
14297
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
14297
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
199547
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
8919
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
204161
Annuals > 2 > balance Sheet > equity
-4614
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-101846
Annuals > 2 > cash Flow > depreciation
-7800
Annuals > 2 > cash Flow > change In Working Capital
-173500
Annuals > 2 > cash Flow > cash From Operations
-88343
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
97590
Annuals > 2 > cash Flow > net Change In Cash
9247
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.009595899257284973
Annuals > 2 > ratios > PB
-126.51540095361942
Annuals > 2 > ratios > ROE
2207.325530992631
Annuals > 2 > ratios > ROA
-51.03860243451418
Annuals > 2 > ratios > FCF
-88343
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-21.802319842053308
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
46308
Annuals > 3 > income Statement > operating Income
-46308
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-46308
Annuals > 3 > income Statement > net Income
-46308
Annuals > 3 > income Statement > eps
-0.004951138672083823
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
9353000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5050
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
8550
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
8550
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
11329
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
11329
Annuals > 3 > balance Sheet > equity
-2779
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-46308
Annuals > 3 > cash Flow > depreciation
46308
Annuals > 3 > cash Flow > change In Working Capital
-42000
Annuals > 3 > cash Flow > cash From Operations
-75348
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
135948
Annuals > 3 > cash Flow > net Change In Cash
60600
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.004951138672083823
Annuals > 3 > ratios > PB
-185.1079525008996
Annuals > 3 > ratios > ROE
1666.35480388629
Annuals > 3 > ratios > ROA
-541.6140350877192
Annuals > 3 > ratios > FCF
-75348
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.0019052164923665086
Valuation > metrics > PB
-1.4969280439019388
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
5.185403631141656
Profitability > metrics > ROA
-180.31924380238985
Profitability > metrics > Net Margin
-6.856900644286199
Profitability > final Score
10
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.2367047308319739
Risk > final Score
25
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.059490716180371356
Liquidity > metrics > Quick Ratio
0.059490716180371356
Liquidity > final Score
13
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
20
Prev Risks > 0
-12
Prev Risks > 1
-84
Prev Risks > 2
1
Prev Liquidities > 0
13
Prev Liquidities > 1
15
Prev Liquidities > 2
18
Updated At
2026-01-20T22:39:42.968Z
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a subsidiary of Worldwide Holdings, LLC.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of SYBLEU INC.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2023-12-31)
(Last Updated 2023-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.